Status:
WITHDRAWN
Predicting Hypotension During Dialysis in the ICU
Lead Sponsor:
Oregon Health and Science University
Conditions:
Peridialytic Hypotension
Eligibility:
All Genders
18+ years
Brief Summary
Currently, decisions regarding volume management for dialysis sessions in the ICU are made in large part on the nephrologists'/intensivists' overall gestalt. This gestalt is based upon a combination o...
Eligibility Criteria
Inclusion
- Admitted to OHSU Hospitals ICUs
- Patient has acute or chronic needs for intermittent hemodialysis support during their ICU stay for any reason other than isolated hyperkalemia
- Central venous access in place separate from the dialysis catheter, or arteriovenous fistula or graft
- Two or more organ systems affected by critical illness requiring supportive care as documented in the medical chart.
Exclusion
- age younger than 18 years old
- Weight \> 160 kg
- burns greater than 40% total body surface area
- known cardiac or vascular aneurysm
- contraindications to femoral arterial puncture
- diagnosis of peripheral vascular disease
- not committed to full support
- participation in other experimental medication trial within 30 days
- current atrial or ventricular arrhythmias
- history of sever CHF- NYHA class \>= III, previously documented EF \< 30%
- severe aortic regurgitation
- anticipated ICU stay \< 24 hrs
- not expected to require dialysis \> 48 hours
Key Trial Info
Start Date :
July 19 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 11 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01171352
Start Date
July 19 2010
End Date
March 11 2013
Last Update
June 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health and Science University
Portland, Oregon, United States, 97239